<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>The authors are employees of BIO Ventures for Global Health (BVGH). BVGH currently receives WIPO Re:Search sponsorship funding from Eisai Co., Ltd.; GlaxoSmithKline; Johnson &amp; Johnson; Merck KGaA; MSD; Novartis; Pfizer; and Takeda Pharmaceutical Company, Ltd, and previously received WIPO Re:Search sponsorship funding from 60P Pharmaceuticals. </p>
</notes>
